|
KLF10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.381800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.059550E-01 |
| Normal-vs-Stage2 |
4.629400E-01 |
| Normal-vs-Stage3 |
1.103000E-01 |
| Normal-vs-Stage4 |
3.144600E-03 |
| Stage1-vs-Stage2 |
1.686190E-02 |
| Stage1-vs-Stage3 |
1.441980E-04 |
| Stage1-vs-Stage4 |
3.56660000422337E-08 |
| Stage2-vs-Stage3 |
4.570000E-01 |
| Stage2-vs-Stage4 |
3.948300E-02 |
| Stage3-vs-Stage4 |
1.575980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.580200E-01 |
| Normal-vs-AfricanAmerican |
5.989200E-01 |
| Normal-vs-Asian |
4.956600E-01 |
| Caucasian-vs-AfricanAmerican |
6.481200E-01 |
| Caucasian-vs-Asian |
5.919000E-01 |
| AfricanAmerican-vs-Asian |
7.365800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.064830E-01 |
| Normal-vs-Female |
5.688300E-02 |
| Male-vs-Female |
1.69186999999793E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.648800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.542400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.192600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.862420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.103390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.398370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.486300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.156800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.531650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.355850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.616100E-02 |
| Normal-vs-Grade 2 |
6.578100E-02 |
| Normal-vs-Grade 3 |
1.242800E-01 |
| Normal-vs-Grade 4 |
5.371800E-04 |
| Grade 1-vs-Grade 2 |
2.148200E-01 |
| Grade 1-vs-Grade 3 |
4.516300E-02 |
| Grade 1-vs-Grade 4 |
1.530190E-02 |
| Grade 2-vs-Grade 3 |
1.59652999999205E-05 |
| Grade 2-vs-Grade 4 |
2.96459967685792E-10 |
| Grade 3-vs-Grade 4 |
6.939500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.079900E-03 |
| Normal-vs-ccB subtype |
5.551600E-04 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.278200E-01 |
| Normal-vs-N1 |
1.6542999999869E-06 |
| N0-vs-N1 |
1.03429999998017E-06 |
|
|
